BCWORLDPHARM Co., Ltd.
Founded 1980, KOSDAQ-listed 2014, BCWORLDPHARM makes anesthetic, antibiotic, and prescription drugs via CMO/CDMO and export operations.
As of 2026-10-10, BCWORLDPHARM Co., Ltd. has 182 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1980 and listed on KOSDAQ in December 2014, BCWORLDPHARM Co., Ltd. is a pharmaceutical manufacturer with subsidiaries BCWorld Healthcare (50%+1 share) and Heart Ad (40%). Its main products are anesthetic and pain drugs, antibiotics, and other prescription drugs, made using facilities including a dedicated carbapenem antibiotics plant. With production facilities compliant with the PIC/s scheme, whose members include the US FDA and European EMA, it runs a CMO business supplying domestic pharmaceutical firms and a CDMO business, exports prescription drugs to Europe, Latin America, the Middle East, CIS countries, and Asia, and has recently begun overseas licensing using its R&D technology.
Products & technology
- Anesthetic and pain-management drugsPrescription drugs for anesthesia and pain management
- Antibiotics (including carbapenem antibiotics)Antibiotic prescription drugs, produced at a dedicated carbapenem antibiotics plant
- Other prescription drugsOther prescription pharmaceuticals
Regulatory approvals
data.go.kr182 Korean MFDS drug approvals · 1991–2026
- MFDS drugVonovar Tablet 20mg (Vonoprazan)2026-05-19Drug · Prescription · Approval202601445
- MFDS drugVonovar Tablet 10mg (Vonoprazan)2026-05-19Drug · Prescription · Approval202601446
- MFDS drugAMVARO OD Tablet 5mg(Amlodipine besylate)2026-04-22Drug · Prescription · Approval202601164
- MFDS drugAMVARO OD Tablet 10mg(Amlodipine besylate)2026-04-22Drug · Prescription · Approval202601165
- MFDS drugStaphinoh Tab. 2/160mg2026-03-26Drug · Prescription · Approval202600861
- MFDS drugBCSUGA prefilled inj. (Sugammadex Sodium)2026-03-20Drug · Prescription · Approval202600799
- MFDS drugTelvaro OD Tablet 40mg (Telmisartan)2025-09-26Drug · Prescription · Approval202502552
- MFDS drugSubsidiary: (주)비씨월드헬스케어Sialanar 320 micrograms/ml oral solution2025-08-08Drug · Prescription · Approval202502064
- MFDS drugTelvaro OD Tablet 80mg (Telmisartan)2025-01-06Drug · Prescription · Approval202500041
- MFDS drugTelampine S Tablet 40/5mg2022-11-08Drug · Prescription · Approval202204035
- MFDS drugTelampine S Tablet 40/2.5mg2022-11-08Drug · Prescription · Approval202204036
- MFDS drugSubsidiary: (주)비씨월드헬스케어Telampin Q Tablet 80/5mg2022-08-26Drug · Prescription · Approval202203404
Show 68 more
- MFDS drugTelampine S Tablet 80/5mg2022-08-25Drug · Prescription · Approval202203377
- MFDS drugBCSUGA Injection (Sugammadex Sodium)2022-02-16Drug · Prescription · Approval202200723
- MFDS drugSubsidiary: (주)비씨월드헬스케어ROSUVARO OD Tablet 5mg (Rosuvastatin calcium(micronized))2021-12-07Drug · Prescription · Approval202107839
- MFDS drugSubsidiary: (주)비씨월드헬스케어ROSUVARO OD Tablet 20mg (Rosuvastatin calcium(micronized))2021-12-07Drug · Prescription · Approval202107840
- MFDS drugSubsidiary: (주)비씨월드헬스케어ROSUVARO OD Tablet 10mg (Rosuvastatin calcium(micronized))2021-12-07Drug · Prescription · Approval202107841
- MFDS drugSUVARO OD Tablet 5mg (Rosuvastatin calcium(micronized))2021-12-02Drug · Prescription · Approval202107780
- MFDS drugSUVARO OD Tablet 10mg (Rosuvastatin calcium(micronized))2021-12-02Drug · Prescription · Approval202107781
- MFDS drugSUVARO OD Tablet 20mg (Rosuvastatin calcium(micronized))2021-12-02Drug · Prescription · Approval202107782
- MFDS drugSubsidiary: (주)비씨월드헬스케어ZETOVA Tablet 10/40 mg2021-02-18Drug · Prescription · Approval202101530
- MFDS drugSubsidiary: (주)비씨월드헬스케어ZETOVA Tablet 10/20 mg2021-02-18Drug · Prescription · Approval202101531
- MFDS drugSubsidiary: (주)비씨월드헬스케어ZETOVA Tablet 10/10 mg2021-02-18Drug · Prescription · Approval202101532
- MFDS drugBC Folic Acid Injection2020-11-12Drug · Prescription · Notification202007804
- MFDS drugSubsidiary: (주)비씨월드헬스케어IPEM-Q Injection 500mg2020-10-30Drug · Prescription · Notification202007456
- MFDS drugBC Morphine Sulfate Injection 1mg/mL (Vial)2020-07-31Drug · Prescription · Approval202005565
- MFDS drugBC Fentanyl Citrate Injection (Vial) (for export)2020-06-22Drug · Prescription · Approval202004529
- MFDS drugDonept Tablet 5mg (Donepezil hydrochloride)2020-04-28Drug · Prescription · Approval202003139
- MFDS drugDonept Tablet 10mg (Donepezil hydrochloride)2020-04-28Drug · Prescription · Approval202003140
- MFDS drugSubsidiary: (주)비씨월드헬스케어Mepem-Q injection 500mg (Meropenem Hydrate)2020-03-27Drug · Prescription · Approval202002133
- MFDS drugSubsidiary: (주)비씨월드헬스케어Mepem-Q injection 1g (Meropenem Hydrate)2020-03-27Drug · Prescription · Approval202002134
- MFDS drugRamoB Injection 0.3mg (Ramosetron HCl)(Vial)2020-01-03Drug · Prescription · Approval202000040
- MFDS drugSTAROVA Tablet 5mg (Rosuvastatin Calcium)Revoked2019-10-15Drug · Prescription · Approval201907231
- MFDS drugSTAROVA Tablet 20mg (Rosuvastatin Calcium)Revoked2019-10-15Drug · Prescription · Approval201907232
- MFDS drugB-lowD Tablet 5mg (s-Amlodipine besylate 2.5 hydrate)2019-09-09Drug · Prescription · Approval201906356
- MFDS drugB-lowD Tablet 2.5mg (s-Amlodipine besylate 2.5 hydrate)2019-09-09Drug · Prescription · Approval201906357
- MFDS drugBC telmi tablet 80mg (Telmisartan)2019-08-30Drug · Prescription · Approval201906188
- MFDS drugBC telmi tablet 40mg (Telmisartan)2019-08-30Drug · Prescription · Approval201906189
- MFDS drugVesid Capsule 5mg (Solifenacin succinate)Revoked2019-08-30Drug · Prescription · Approval201906203
- MFDS drugVesid Capsule 10mg (Solifenacin succinate)Revoked2019-08-30Drug · Prescription · Approval201906204
- MFDS drugNARCO Sublingual Tablet 300μg (Fentanyl Citrate)2018-11-09Drug · Prescription · Approval201804456
- MFDS drugNARCO Sublingual Tablet 200μg (Fentanyl Citrate)2018-10-17Drug · Prescription · Approval201804098
- MFDS drugThycare Injection ( Thymocin α 1 )2018-07-20Drug · Prescription · Approval201803018
- MFDS drugBC Atracurium Besilate Injection 25mg/2.5mL (for export)2018-06-15Drug · Prescription · Notification201802514
- MFDS drugBC Sodium Hydrogen Carbonate Injuction 8.4% (for export)2018-06-08Drug · Prescription · Notification201802390
- MFDS drugBC Pregabalin Capsule 150mg (for export)2018-02-08Drug · Prescription · Approval201800762
- MFDS drugBC Pregabalin Capsule 75mg (for export)2018-02-08Drug · Prescription · Approval201800763
- MFDS drugLirics-R tablet 480mg (R-thioctic acid tromethamine)2018-01-16Drug · Prescription · Approval201800229
- MFDS drugMultipotent 9 Injection2017-12-22Drug · Prescription · Approval201708543
- MFDS drugNUCYNTA ER Tablet 200mg2017-12-15Drug · Prescription · Approval201708383
- MFDS drugJext prefilled pen injection 150μg (Epinephrine bitartate)2017-12-14Drug · Prescription · Approval201708377
- MFDS drugJext prefilled pen injection 300μg (Epinephrine bitartate)2017-12-14Drug · Prescription · Approval201708378
- MFDS drugNUCYNTA IR Tablet 50mg2017-11-16Drug · Prescription · Approval201707914
- MFDS drugNARCO Sublingual Tablet 100μg (Fentanyl Citrate)2017-10-24Drug · Prescription · Approval201707583
- MFDS drugNepoxin Vigial Soft capsule2017-08-18Drug · Prescription · Notification201706655
- MFDS drugBC Clindamycin phosphate Injection (for export)2017-01-03Drug · Prescription · Notification201700040
- MFDS drugBC Dobutamine HCl Injection (for export)2017-01-02Drug · Prescription · Notification201700010
- MFDS drugMultipotent 5 Injection2016-08-26Drug · Prescription · Notification201605115
- MFDS drugRelix Injection (Thiotic acid)2016-07-21Drug · Prescription · Notification201604505
- MFDS drugBC Morphine Sulfate Injection 10mg/mL (Vial)2016-06-29Drug · Prescription · Approval201604036
- MFDS drugNUCYNTA ER Tablet 100mg2016-06-10Drug · Prescription · Approval201603372
- MFDS drugNUCYNTA ER Tablet 50mg2016-06-10Drug · Prescription · Approval201603373
- MFDS drugGardien Tablet 1000mg (Ecabet Sodium)(for export)2016-03-25Drug · Prescription · Approval201601623
- MFDS drugTUTOL Tablet 800mg (Ethambutol hydrochloride)Revoked2015-10-30Drug · Prescription · Approval201507463
- MFDS drugQuinox Injection 400mg (Moxifloxacin)2015-09-30Drug · Prescription · Approval201506838
- MFDS drugJOYRON Forte Injection (pre-filled) (Sodium hyaluronate)2015-09-22Drug · Prescription · Notification201506675
- MFDS drugMUCOLESS Capsule 200mg (Acetylcysteine)Revoked2015-09-15Drug · OTC · Notification201506556
- MFDS drugGUTHIONE Injection 1200mg (Glutathione(reducted))2015-08-31Drug · Prescription · Notification201506146
- MFDS drugBC Thioctic acid HR Tablet 600mg (for export)2015-07-20Drug · Prescription · Approval201504946
- MFDS drugBC Piracetam Injection 1g (for export)2015-07-10Drug · Prescription · Notification201504759
- MFDS drugBC Pantoprazole Sodium Sesquihydrate Injection (for export)2015-07-08Drug · Prescription · Notification201504694
- MFDS drugBC Pralidoxime Chloride Injection 500mg (for export)2015-07-07Drug · Prescription · Notification201504625
- MFDS drugSufental Injection 50mcg/mL (Sufentanil Citrate)2015-07-03Drug · Prescription · Approval201504505
- MFDS drugBC Pethidine HCl Injection (for export)2015-07-03Drug · Prescription · Approval201504506
- MFDS drugBC Morphine Sulfate Injection 5mg (for export)2015-07-03Drug · Prescription · Approval201504507
- MFDS drugBC Morphine Sulfate Injection 10mg (for export)2015-07-03Drug · Prescription · Approval201504508
- MFDS drugBC Fentanyl Citrate Injection (for export)2015-07-03Drug · Prescription · Approval201504512
- MFDS drugTivare Injection 1mg(remifentanil hydrochloride)(for export)2015-07-03Drug · Prescription · Approval201504513
- MFDS drugTivare Injection 2mg(remifentanil hydrochloride)(for export)2015-07-03Drug · Prescription · Approval201504514
- MFDS drugTivare Injection 5mg(remifentanil hydrochloride)(for export)2015-07-03Drug · Prescription · Approval201504515
Showing the 80 most recent of 182 records.
Clinical trials
data.go.kr40 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 24 · Phase 1 15 · Phase 3a 1)
- BioequivalenceBCWP_D0032026-09-02
2 trial sites
- BioequivalenceG26012026-04-20
1 trial site
- Phase 1G23062026-04-13
2 trial sites
- Phase 1G2006-T2025-09-09
2 trial sites
- BioequivalenceG22032025-04-16
2 trial sites
- Phase 1G23022024-11-08
2 trial sites
- Phase 1G24022024-10-30
2 trial sites
- Phase 1G23062024-08-21
2 trial sites
- Phase 1G2007-T2024-01-03
2 trial sites
- BioequivalenceG2015-T2023-12-19
2 trial sites
- Phase 1G1906-T2023-11-24
2 trial sites
- Phase 1G2006-T2023-07-31
2 trial sites
Show 28 more
- BioequivalenceG1905-T2021-12-01
2 trial sites
- BioequivalenceG1906-T2021-11-09
2 trial sites
- BioequivalenceG1909-T2021-07-06
2 trial sites
- BioequivalenceG1908-T2020-09-04
1 trial site
- Bioequivalence나르코설하정400마이크로그램(펜타닐시트르산염)2019-10-02
1 trial site
- Phase 1티카렐A (BCWP_C005)2019-07-22
1 trial site
- Bioequivalence레니트오디정(라사길린메실산염)2018-10-05
2 trial sites
- Bioequivalence키졸브정2밀리그램(프루칼로프라이드숙신산염)2018-03-05
2 trial sites
- Phase 3aBCWP_C0032017-07-13
- Bioequivalence리릭스알정480밀리그램(알티옥트산트로메타민염)2017-05-04
2 trial sites
- BioequivalenceBCWP_D004주2017-04-28
2 trial sites
- Bioequivalence세르티정(레보세티리진염산염2.5mg/슈도에페드린염산염120mg)2016-10-19
2 trial sites
- Bioequivalence비씨솔리페나신구강붕해정10밀리그램(솔리페나신숙신산염)2015-11-18
2 trial sites
- Bioequivalence비씨실로도신구강붕해정8밀리그램(실로도신)2015-10-14
2 trial sites
- Bioequivalence비씨리스페리돈구강붕해정1밀리그램(가칭)2015-09-24
- Bioequivalence비씨펜타닐시트르산염설하정100마이크로그램(펜타닐시트르산염)2015-09-10
2 trial sites
- Bioequivalence가디엔정 1000밀리그램(에카베트나트륨수화물)2015-06-18
2 trial sites
- Bioequivalence테람핀정 80/5밀리그램(Amlodipine 5mg, Telmisartan 80mg)2014-11-21
2 trial sites
- Bioequivalence비씨에스오메프라졸캡슐40밀리그램2014-05-21
2 trial sites
- Bioequivalence쎄레티스캡슐 200밀리그램(세레콕시브)2014-02-18
2 trial sites
- Phase 1BCWP_D009주2013-10-07
- Phase 1BCWP_C0032013-08-21
- Bioequivalence비씨아토르바스타틴정20밀리그램2013-08-12
2 trial sites
- Phase 1BCWP_C0032013-06-04
1 trial site
- Phase 1BCWP_C0032012-10-25
- Phase 1BCWP_A0012012-05-31
- Phase 1BCWP_A0012012-05-09
- Bioequivalence듀오맥스정2012-03-09
Patents
KIPRIS · applicant-matchedRejected · 2019-07 · Application 1020190092158
Withdrawn · 2017-04 · Application 1020170050984
Registered · 2014-08 · Application 1020140102640
Rejected · 2014-08 · Application 1020140102643
Withdrawn · 2012-12 · Application 1020120155502
Expired · 2012-11 · Application 1020120134883
Registered · 2012-11 · Application 1020120128901
Expired · 2012-09 · Application 1020120108653
Registered · 2012-04 · Application 1020120043140
Registered · 2011-06 · Application 1020110056387
Show 12 more patents
Registered · 2011-05 · Application 1020110051595
Expired · 2011-05 · Application 1020110051516
Registered · 2010-12 · Application 1020127020145
Registered · 2010-12 · Application 1020100134722
Registered · 2010-11 · Application 1020100115825
Registered · 2010-11 · Application 1020100112714
Rejected · 2010-05 · Application 2020100005534
Registered · 2010-05 · Application 1020100042672
Expired · 2010-04 · Application 1020100034569
Expired · 2010-03 · Application 1020100025921
Registered · 2010-02 · Application 1020100016546
Expired · 2007-04 · Application 1020070037919
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot77
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for BCWORLDPHARM Co., Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition